![]() |
|
|
Vol. 13, Issue 6, 2001-2015, June 2002
Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-5055
Submitted January 30, 2002; Revised March 25, 2002; Accepted March 27, 2002| |
ABSTRACT |
|---|
|
|
|---|
The aryl hydrocarbon receptor (AhR or dioxin receptor) is a
ligand-activated transcription factor that heterodimerizes with the AhR
nuclear translocator (ARNT/HIF-1
) to form an AhR/ARNT transcription
factor complex. This complex binds to specific DNA sites in the
regulatory domains of numerous target genes and mediates the biological
effects of exogenous ligands. Herein, we have investigated the
subcellular distribution of the AhR/ARNT complex in response to ligand
stimulation, by using live-cell confocal and high-resolution deconvolution microscopy. We found that unliganded AhR shows a predominantly cytoplasmic diffuse distribution in mouse hepatoma cells.
On addition of ligand, AhR rapidly translocates to the nucleus and
accumulates in multiple bright foci. Inhibition of transcription
prevented the formation of AhR foci. Dual- and triple-immunolabeling experiments, combined with labeling of nascent RNA, showed that the
foci are transcription sites, indicating that upon ligand stimulation,
AhR is recruited to active transcription sites. The interaction of AhR
with ARNT was both necessary and sufficient for the recruitment of AhR
to transcription sites. These results indicate that AhR/ARNT complexes
are recruited to specific subnuclear compartments in a ligand-dependent
manner and that these foci represent the sites of AhR target genes.
| |
INTRODUCTION |
|---|
|
|
|---|
Aryl hydrocarbon receptor (AhR or dioxin receptor) is a member of
basic helix-loop-helix (bHLH)/PAS (Period [Per]-aryl hydrocarbon receptor nuclear translocator [ARNT]-single minded [Sim]) family of
transcriptional regulators (Burbach et al., 1992
; Ema
et al., 1992
). Members of this family include aryl
hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1
(ARNT/HIF-1
) (Hoffman et al., 1991
), hypoxia-inducible
factor 1
(HIF-1
) (Wang et al., 1995
),
Drosophila developmental factors such as Trachealess (Isaac
and Andrew, 1996
; Wilk et al., 1996
) and Sim (Nambu et al., 1991
), mammalian circadian rhythm regulators such as Clock (King et al., 1997
) and Per (Sun et al., 1997
;
Tei et al., 1997
), and nuclear receptor coactivators such as
SRC-1 (Kamei et al., 1996
) and TIF-2 (Voegel et
al., 1996
). Although these regulatory proteins form
heterodimers and to a lesser degree homodimers with other family
members, ARNT is the only known heterodimerization partner of AhR. The
bHLH/PAS proteins play roles in neurogenesis, myogenesis, circadian
rhythm regulation, homeostatic response to hypoxia, toxin metabolism,
and nuclear hormone receptor function (Crews, 1998
; Gu et
al., 2000
).
AhR is a ligand-activated transcription factor. Endogenous ligand(s) of
AhR is unknown. Both genetic and biochemical studies indicate that AhR
plays a role in embryonic development, liver and immune system
functioning, and cell growth and differentiation (Fernandez-Salguero
et al., 1995
; Ma and Whitlock, 1996
; Schmidt et
al., 1996
; Kolluri et al., 1999
). Exogenous ligands of
AhR include a variety of halogenated and polycyclic aromatic
hydrocarbons that are found in environmental pollutants, chemical
carcinogens, and tobacco smoke, and AhR has been directly linked to
carcinogenesis by these compounds (Hankinson, 1995
; Rowlands and
Gustafsson, 1997
; Shimizu et al., 2000
).
ARNT/HIF-1
is a bHLH/PAS transcription factor, and it is not
believed to bind to any ligand (Hoffman et al., 1991
).
Genetic and biochemical studies show that ARNT is crucial in embryonic development and angiogenesis and in response to hypoxia and
hypoglycemia (Maltepe et al., 1997
).
The unliganded form of AhR exists in a complex with heat-shock protein
90 (hsp90) and an immunophilin-type chaperon and is diffusely
distributed in the cytoplasm (Pollenz et al., 1994
; Carver
and Bradfield, 1997
; Meyer et al., 1998
). After ligand binding, activated AhR translocates to the nucleus. In contrast to AhR,
ARNT localizes in the nucleus both in the presence and absence of
ligand (Hord and Perdew, 1994
; Pollenz et al., 1994
). AhR
dissociates from the hsp90 and heterodimerizes with ARNT, and the
AhR/ARNT complex activates the transcription of target genes by binding
to specific xenobiotic response elements (XREs) or dioxin response
elements. Both AhR and ARNT function at the endpoints of a
variety of signal transduction pathways, thereby regulating the
expression of specific genes involved in cell growth, differentiation,
metabolism of drugs, and environmental carcinogens. Examples of
AhR/ARNT target genes, identified to date include cytochromes P450 1A1,
1A2, 1B1, glutathione S-transferase, and NADPH/quinone
oxidoreductase (Rowlands and Gustafsson, 1997
; Whitlock, 1999
).
The spatial distribution of transcription factors with respect to
active transcription sites has been studied for a small number of
transcription factors (van Steensel et al., 1995
; Grande et al., 1997
; Zeng et al., 1998
; Rubbi and
Milner, 2000
). However, the dynamic recruitment of a specific
transcription factor and its heterodimerization partner to active
transcription sites in a ligand-dependent manner has never been
demonstrated in living cells. Herein, we have used high-resolution
confocal and deconvolution microscopy to study the intracellular and
intranuclear distribution of the AhR/ARNT transcription factor complex
in vivo. We show that AhR is recruited to transcription sites from the
nuclear receptor complexes and that heterodimerization partner ARNT is both necessary and sufficient for the recruitment. These results indicate that AhR/ARNT complexes are recruited to specific subnuclear compartments (foci) in a ligand-dependent manner and that these foci
represent the sites of AhR target genes.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Expression Vectors
The mouse ARNT expression vector pcDNAI/Neo/mARNT has been
described previously (Reisz-Porszasz et al., 1994
; kindly
provided by Dr. O. Hankinson, University of California, Los Angeles,
CA). P1A1-4X1-LUC contains four copies of XRE1 immediately upstream of
the P450 1A1 gene promoter and a luciferase reporter gene. XRE1 is a
natural high-affinity binding site for the ligand-activated AhR/ARNT
complex. P1A1-LUC is similar to P1A1-4X1-LUC except it lacks the four
copies of XRE1. Both expression vectors have been described previously
(Xu et al., 1998
; a gift from Dr. D. Pasco, University of
Mississippi, Oxford, MS). PCMV
gal was purchased from
Pharmacia Biotech (Piscataway, NJ). Green fluorescent protein (GFP)-AhR was generated by amplifying the AhR insert from pCI/AhR (a
generous gift from Dr. F.J. Gonzalez, National Cancer Institute, Bethesda, MD) by using primers 5'-GCGCAAGCTTCAAGCAGCGGCGCCAACATC-3' and
5'-AAGGCCGCGGCTCCTCAACTCTGCACCTT-GC-3'. The final polymerase chain
reaction product was cloned into pEGFP-C1 vector (CLONTECH, Palo Alto,
CA). The resulting GFP-AhR vector was confirmed by sequencing and
restriction analysis.
Cell Culture
The wild-type mouse hepatoma cell line (Hepa-1) and its
variants, group B (AhR-deficient) and group C (ARNT mutant), have been
described previously (Hankinson, 1995
). Cells were grown in
-minimum
essential medium (Invitrogen, Carlsbad, CA) supplemented with
7% fetal bovine serum (Hyclone Laboratories, Logan, UT). Cells were
routinely maintained in a 37°C incubator with 5%
CO2. Cells were treated with control vehicle,
dimethyl sulfoxide (DMSO), or with a ligand,
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), at 10 nM for
1 h in all experiments. Inhibition of RNA polymerase II was
achieved by treatment with
-amanitin (Sigma-Aldrich, St. Louis, MO)
at 30 µg/ml for 3-4 h.
Transfections and Immunoblot Analysis
Expression constructs were transiently transfected into
AhR-deficient and ARNT mutant cells by electroporation with a Electro Square Porator (BTX, San Diego, CA) at 160 V for 70 ms. The amount of
transfected vectors was 5 µg of each GFP-AhR, AhR, GFP empty vector,
P1A1-4X1-LUC, P1A1-LUC, and pcDNAI/Neo/mARNT and 1 µg of PCMV
gal
(as an internal control). After 14 h, cells were treated either
with control vehicle or TCDD at 10 nM for 1 h. The cells were
harvested, and luciferase and
-galactosidase assays were done by
using the Dual Reporter Assay according to the manufacturer's instructions (Tropix, Bedford, MA). All transfections were done in
triplicates and all experiments were repeated at least four times. For
Western blot, AhR-deficient cells were transfected with GFP-AhR and
pCMV-IL2 as described above. The following day, the transfected
population of cells was isolated by sorting using anti-IL2-coated
magnetic beads, and whole cell extracts were prepared as described
previously (Lim et al., 1999
). Whole cell extracts were also
prepared from wild-type Hepa-1 cells. Equal amounts of total cell
extracts were fractioned on a 7.5% SDS-PAGE gels, electrotransferred
to Immobilon-P (Millipore, Bedford, MA). GFP-AhR and endogenous AhR
were detected using polyclonal anti-AhR (BIOMOL Research Laboratories,
Plymouth Meeting, PA) and a horseradish peroxidase-conjugated goat
anti-rabbit (Pierce Chemicals, Rockford, IL) antibody.
Immunoblots were stripped and reprobed with monoclonal anti-tubulin as a loading control (Sigma-Aldrich). Expression of fusion
protein was also confirmed by two other antibodies: monoclonal anti-GFP
(Berkeley Antibody Company, Berkeley, CA) and polyclonal anti-AhR
(Santa Cruz Biotechnology, Santa Cruz, CA).
Live-Cell Microscopy
AhR-deficient cells were grown and observed in LabTek II chambers (Nalge Nunc International, Naperville, IL). Subconfluent cells were transfected with GFP-AhR by electroporation as described above or by GenePorter Transfection Reagent (Gene Therapy Systems, San Diego, CA) according to manufacturer's instructions. After 14 h, the midplane single optical section of a cell was imaged before and 15, 30, and 60 min after the addition of 10 nM TCDD on a TCS NT laser scanning confocal microscope equipped with a 100× 1.4 numerical aperture (NA), oil immersion lens (Leica Microsystems, Deerfield, IL). GFP was excited with the 488-nm line from an argon laser (20-mW nominal output, detection 505-575 nm by using a photon multiplier tube with the confocal pinhole setting at 1.0 Airy disk unit). Data were collected with fourfold averaging at a resolution of 1024 × 1024 pixels by using optical slices of ~0.4 µm. All experiments were done at 37°C.
In Situ Labeling of Transcription Sites
Nascent RNA was labeled based on procedures described previously
(Jackson et al., 1993
; Wansink et al., 1993
;
Huang et al., 1998
; Wei et al., 1999
). Briefly,
cells were grown on 22-mm square glass coverslips in a six-well
plate and transfected with GFP-AhR and treated with TCDD as described
above. The cells were permeabilized in Tris-glycerol buffer (20 mM
Tris-HCl, pH 7.4, 5 mM MgCl2, 0.5 mM EGTA, 25%
glycerol, 5 µg/ml digitonin, 0.5 mM phenylmethylsulfonyl fluoride,
and recombinant RNasin at 20 U/ml) for 3 min at room temperature. The
cells were then incubated for 5 min at 35°C in transcription buffer
(100 mM KCl, 50 mM Tris-HCl, pH 7.4, 5 mM MgCl2,
0.5 mM EGTA, 25% glycerol, 2 mM ATP, 0.5 mM CTP, 0.5 mM GTP, 0.5 mM
5-bromouridine 5'-triphosphate [BrUTP] [Sigma-Aldrich]), 1 mM
phenylmethylsulfonyl fluoride, and recombinant RNasin at 20 U/ml. The
cells were fixed and processed for indirect immunofluorescence microscopy as described below. Similar results were obtained by incubation in the transcription buffer for 30 min at room temperature and by using a protocol that labels the nascent RNA by microinjection of BrUTP (Wansink et al., 1994
). Detection of transcription
sites was confirmed by the absence of nascent RNA labeling after
treatment with actinomycin D. Labeling of nuclear, but not nucleolar
nascent RNA was sensitive to
-amanitin (2 µg/ml) when included in
the transcription buffer. No nascent RNA signal was detected when cells
were treated with RNase A before fixation.
Deconvolution Microscopy
AhR-deficient cells were grown on 22-mm square glass coverslips in a six-well plate, transfected with GFP-AhR, and treated with TCDD as described above. The cells were fixed and processed for indirect immunofluorescence microscopy as described below. Three-dimensional image stacks of cells were collected on an IE80 inverted microscope equipped with a 100× 1.35 NA, oil immersion objective (both from Olympus, Tokyo, Japan), and a charge-coupled device camera (Photometrics, Tucson, AZ) configured at 0.070-µm pixels. These three-dimensional image stacks were composed of 128 focal planes (in the Z-plane) with a spacing of 0.07 µm and were deconvolved by a constrained iterative deconvolution algorithm by using Deltavision image acquisition and analysis software (Applied Precision, Issaquah, WA). The midplane single optical sections of representative cells are shown in the figures.
Immunofluorescence Microscopy
AhR-deficient, ARNT mutant, and wild-type Hepa-1 cells
were grown on 22-mm square glass coverslips in a six-well plate,
transfected with GFP-AhR, and treated with TCDD as described above. The
cells were fixed in 2% paraformaldehyde and processed for indirect
immunofluorescence microscopy as described previously (Misteli and
Spector, 1996
). The primary antibodies used in this study included
polyclonal anti-AhR at 1:1000 (BIOMOL Research Laboratories),
polyclonal anti-AhR and anti-ARNT at 1:500 (Santa Cruz Biotechnology),
monoclonal anti-ARNT at 1:250 (Affinity Bioreagents, Golden, CO),
monoclonal anti-NuMa at 1:200 (Transduction Laboratories, Lexington,
KY), and monoclonal anti-BrU at 1:250 (Caltag Laboratories, Burlingame, CA, or Roche Applied Science, Indianapolis, IN). The primary antibodies used for double and triple labelings were from different species including mouse, rabbit, and goat. We used species-specific secondary antibodies designed for simultaneous multiple labeling (Jackson Immunoresearch Laboratories, West Grove, PA). Secondary antibodies were
conjugated to fluorescein isothiocyanate, Texas Red, and Cy-5. Images
were acquired with narrow-band-pass emission filters (Chroma
Technology, Brattleboro, VT) to prevent bleed-through between the
channels. We obtained similar results by using rhodamine Red-X-conjugated secondary antibodies (Jackson Immunoresearch Laboratories) in place of those conjugated with Texas Red. DNA was
stained with diamidino-phenylindole, dihydrochloride (Molecular Probes,
Eugene, OR). Cells were mounted using Vectashield (Vector Laboratories,
Burlingame, CA). The cells were observed on a deconvolution microscope
as described above or on an E800 microscope (Nikon, Tokyo,
Japan) by using 100× 1.35 NA, oil immersion Plano Nikon objective and a MicroMax cooled charge-coupled device camera
(Photometrics). Images were collected and analyzed by using MetaMorph
software (Universal Imaging, Downingtown, PA).
Cross-Correlation Analysis
Dual- and triple-immunolabeled images were collected
on a deconvolution microscope as described above and cross-correlation function (CCF) analyses were carried out as described previously (van
Steensel et al., 1996
; Grande et al., 1997
)
by using MetaMorph software. Briefly, CCF of red signals (e.g.,
transcription sites) and green signals (e.g., GFP-AhR sites) was
calculated by shifting the midplane single optical section of green
image with respect to the midplane single optical section of red image
over a distance of
X (in pixels) along the x-axis. The
X shift varied between
30 to +30 pixels. Negative
X values
indicate the position of the green image to the left of the red image
and positive
X values indicate the position of the green image to
the right of the red image. After each
X shift, Pearson's
correlation coefficient (Rp) representing the overlap between the
images was calculated (Gonzalez and Wintz, 1987
), and the Rp values
were plotted against the
X values to generate the CCF graph. The
value of Rp ranges between
1 and +1. A maximum Rp value and a peak
around
X = 0 indicate a positive correlation between the
distributions of red and green signals resulting from a high degree of
nonrandom colocalization between two distributions. A minimum Rp value
with an inverse peak around
X = 0 indicates no correlation
between the distributions of red and green signals resulting from
mutually excluded distributions. Even Rp values throughout the CCF
graph with neither a positive nor an inverse peak around
X = 0 indicate colocalization of red and green signals resulting from a
random overlap.
Quantitation of Colocalizations
Colocalization percentages in Table
1 were generated using 100 randomly
selected cells from five independent experiments. The cells were dual-
or triple-immunolabeled and imaged on a deconvolution microscope as
described above. Single optical sections from the middle of cells were
used for quantitations. The red and the green fluorescent signals with
the fluorescent intensity values ranging only within the top 40% for
that fluorescent channel were identified by thresholding with MetaMorph
software. The percentage of pixels having the same positions in both
thresholded images was calculated and included in Table 1.
Colocalizations of the signals were confirmed by examining the
consecutive optical sections above and below the midplane optical
sections covering the entire depth of the cell nuclei. The
colocalization image in Figure 6E was generated by thresholding the
images with AhR, BrUTP, and ARNT signals from a representative cell as
described above. The images were then converted to grayscale binary
image, and the pixels containing the three signals simultaneously were
output as a separate image.
|
Online Supplemental Material
Cross-Correlation Analyses of Randomly and Positively Associated Distributions. As negative and positive controls of cross-correlation analyses, AhR-deficient cells transiently expressing GFP-AhR were treated for 1 h with 10 nM TCDD. Cells were fixed and nuclear mitotic apparatus protein (NuMa) was detected using a specific antibody (B). GFP-AhR was detected using an anti-AhR antibody and either a Cy-5- (D) or a Texas Red-conjugated (E) secondary antibody. GFP-AhR and NuMa distributions were visualized by deconvolution microscopy as described in MATERIALS AND METHODS. Single optical sections from the middle of cells are shown. In the overlays, yellow-orange indicates colocalizations (C and F). The arrows point to the positions of linescans. Areas marked by a rectangle are enlarged and shown as insets. Linescan and CCF analyses of GFP-AhR and NuMa distributions (G and I) or AhR (green, Cy-5-conjugated secondary antibody) and AhR (red, Texas Red-conjugated secondary antibody) distributions (H and J) are shown. NuMa did not colocalize with GFP-AhR, and the nuclear distributions of GFP-AhR and NuMa were associated randomly. In contrast, complete colocalization was observed between the two AhR distributions and two distributions were highly positively correlated (bars, 2 µm). These results demonstrated that transcription-unrelated nuclear protein, NuMa associate with AhR randomly, suggesting that the observed association of AhR with active transcription sites is not fortuitous.
| |
RESULTS |
|---|
|
|
|---|
Intracellular Localization of Endogenous AhR and ARNT
We examined the intracellular localization of endogenous AhR and
endogenous ARNT in wild-type Hepa-1 cells by indirect
immunofluorescence microscopy with anti-AhR and anti-ARNT antibodies.
In wild-type Hepa-1 cells, endogenous AhR is diffusely distributed in
the cytoplasm in the absence of TCDD (Figure
1A). After TCDD treatment, endogenous AhR
translocated almost completely to the nucleus and distributed in
multiple bright foci in addition to a diffuse nucleoplasmic background
(Figure 1B). In contrast, endogenous ARNT localized to the nucleus in
numerous small foci both in the absence and in the presence of ligand
(Figure 1, C and D).
|
Characterization and Intracellular Localization of GFP-AhR
To probe the behavior of AhR/ARNT complex in living cells, the GFP
was fused in-frame to the amino terminus of AhR (Figure 2A). We first checked the expression of
the GFP-AhR fusion and compared it with the expression of endogenous
AhR. AhR-deficient cells were transiently transfected with GFP-AhR and
pCMV-IL2. The transfected cell population was isolated by sorting with
anti-IL2-coated magnetic beads, and whole cell extracts from
AhR-deficient and wild type Hepa-1 cells were analyzed by Western
blotting with anti-AhR antibody. AhR-deficient cells are derived from
wild-type Hepa-1 cells and have <10% of wild-type AhR levels (Figure
2B; Legraverend et al., 1982
). GFP-AhR was expressed as a
117-kDa protein (Figure 2B; 90 kDa for mouse AhR and 27 kDa for GFP). The expression level of GFP-AhR in AhR-deficient cells was similar to
the expression level of endogenous AhR in wild-type Hepa-1 cells
(Figure 2B). Expression of GFP-AhR fusion was also confirmed by a
monoclonal anti-GFP antibody (our unpublished data). We tested the functional activity of GFP-AhR in vivo by cotransfection into the
AhR-deficient cells with a reporter gene containing the P450 1A1
promoter and upstream regulatory sequences. P450 1A1 is the most
thoroughly studied target gene of the AhR/ARNT transcription factor
complex (Whitlock, 1999
). GFP-AhR activated the reporter gene
transcription approximately fivefold in a TCDD-dependent manner. This
activation was similar to that observed with untagged AhR (Figure 2C).
In contrast, expression of GFP alone did not activate transcription.
|
To visualize the intracellular distribution of GFP-AhR, AhR-deficient
cells were transfected and treated with either DMSO as a control or
TCDD. The cells were fixed and GFP-AhR fluorescence was detected by
epifluorescence microscopy. Transiently expressed GFP-AhR behaved
identically to endogenous AhR both in the absence or presence of TCDD
(compare Figure 2, D and E, with 1, A and B). Identical results were
observed using HeLa cells or using different cell fixation methods (our
unpublished data). In AhR-deficient cells, endogenous AhR was
undetectable by indirect immunofluorescence with or without TCDD
treatment (our unpublished data). To determine the kinetics of
translocation of GFP-AhR in living cells, we carried out time-lapse
confocal microscopy on AhR-deficient cells transiently expressing
GFP-AhR. TCDD-dependent rapid nuclear translocation and the formation
of AhR foci were observed as early as 15 min after the treatment with
TCDD (Figure 2G). After 60 min of TCDD treatment, GFP-AhR predominantly
localized to the nucleus and accumulated in distinct foci (Figure 2I).
No nuclear translocation of GFP-AhR or endogenous AhR occurred at
4°C, consistent with the thesis that the ligand-dependent
activation and the nuclear translocation of AhR are
temperature-dependent processes (our unpublished data; Pollenz
et al., 1994
; Hankinson, 1995
).
Inhibition of Transcription Prevents Formation of GFP-AhR Foci
Because both the AhR and the ARNT localized in intranuclear foci
reminiscent of transcription sites, we next determined whether the
intranuclear foci were sites of transcription. AhR-deficient cells
transiently expressing GFP-AhR were first treated with the specific
inhibitor of RNA polymerase II,
-amanitin at 30 µg/ml, and then
with TCDD (Figure 3C) or were first
treated with TCDD and then with
-amanitin at 30 µg/ml (Figure 3D).
In cells imaged after
-amanitin treatment, no intranuclear foci were
observed, although the intranuclear diffuse distribution could still be observed (Figure 3, C and D). This result suggests that AhR foci are
linked to RNA polymerase II transcription and the foci might correspond
to the sites of transcription. Identical results were obtained using
actinomycin D at 5 µg/ml for 1 h (our unpublished data).
|
Recruitment of AhR to Active Transcription Sites
To test more directly whether the spatial distribution of AhR in
the nucleus is related to the spatial distribution of the nascent RNA,
we labeled the nascent RNA in situ by using BrUTP incorporation.
Incorporation of BrUTP into newly transcribed RNA permits the detection
of transcription initiation sites, i.e., RNA bound to RNA polymerase
engaged in transcription (Jackson et al., 1993
; Wansink
et al., 1993
). AhR-deficient cells transiently expressing
GFP-AhR were treated with TCDD, fixed, and nascent transcripts were
detected using anti-BrU antibody. The distribution of GFP-AhR and
active transcription sites was visualized by deconvolution microscopy
(Figure 4, A and B). Considerable
colocalization was detected between GFP-AhR and active transcription
sites (Figure 4C). The presence or absence of AhR at the active
transcription sites was verified by linescan analyses. A representative
linescan in Figure 4D demonstrates that some but not all fluorescence
intensity peaks from both signals coincided. We used CCF analysis to
test whether the spatial distributions of GFP-AhR and the active
transcription sites are correlated. CCF is a method to determine
whether the spatial distributions of two signals are correlated in
random or nonrandom manner (van Steensel et al., 1996
;
Grande et al., 1997
). CCF analysis showed a peak and a
maximum Rp value around
X = 0, indicating that observed
colocalizations between GFP-AhR and the active transcription sites were
positively correlated and nonrandom (Figure 4E, see "Online
Supplemental Material"). Quantitation of the colocalization
percentages as described in MATERIALS AND METHODS showed that 35% of
AhR foci colocalized with the sites of active transcription, suggesting
that only a subpopulation of AhR foci represent active transcription
sites (Table 1).
|
AhR Associates with ARNT/HIF-1
at Transcription Sites
Although coimmunoprecipitation and footprinting assays have
indicated that AhR forms a complex with ARNT and that AhR/ARNT heterodimeric complex binds to DNA, no in vivo evidence for their simultaneous presence at transcription sites has been provided (Probst
et al., 1993
; Ko et al., 1996
). To probe the
association of AhR with ARNT at transcription sites in vivo, we
examined the intranuclear distributions of both proteins by using
indirect immunofluorescence combined with deconvolution microscopy.
AhR-deficient cells transiently expressing GFP-AhR were treated with
TCDD, fixed, and endogenous ARNT was detected using anti-ARNT antibody
(Figure 5, A and B). The overlay image
shows that AhR significantly colocalized with ARNT (Figure 5C). This
result was supported by linescans and CCF analyses. A representative
linescan indicates the overlap of some but not all fluorescence
intensity peaks from both signals (Figure 5D). The CCF graph shows a
maximum Rp value and a peak around
X = 0, indicating a
positively correlated, nonrandom colocalization between two
distributions (Figure 5E). Quantitation of the colocalization percentages as described in MATERIALS AND METHODS showed that 38% of
AhR distribution colocalized with ARNT distribution (Table 1). This
observation suggests that a subpopulation of AhR associates with ARNT.
|
The pairwise partial colocalization of AhR with transcription sites and
AhR with ARNT suggested the possibility that AhR and ARNT colocalize at
transcription sites. To test this, we analyzed the intranuclear
distributions of AhR, ARNT, and transcription sites simultaneously.
AhR-deficient cells transiently expressing GFP-AhR were treated with
TCDD, and nascent RNA was labeled by BrUTP incorporation. The cells
were processed for indirect immunofluorescence combined with
deconvolution microscopy by using anti-BrU and anti-ARNT antibodies
(Figure 6, A-C). The overlay and
colocalization images show that transcription sites colocalized with
GFP-AhR and ARNT (Figure 6D, beige-yellow regions and E). The presence
of GFP-AhR and ARNT at the same transcription site was confirmed by
linescans. A representative linescan shows that fluorescent intensity
peaks from the three signals frequently coincided (Figure 6F). CCF
analyses of all three distributions with each other indicated positive correlation peaks around
X = 0 (Figure 6, G-I). Quantitative analysis of 45 randomly selected nuclei by randomly generated linescans
showed that when AhR is recruited to transcription sites, ARNT is
present at the same transcription site 86.5% of the time (SD = 3.5, SEM = 0.73; data derived from four independent experiments). These results indicate that AhR associates with ARNT at active transcription sites. Quantitation of the colocalization percentages in
images such as Figure 6E as described in MATERIALS AND METHODS showed
that 31 ± 4% (mean ± SD) of AhR is at active transcription sites with ARNT.
|
ARNT Is Necessary and Sufficient for Recruitment of Endogenous AhR to Active Transcription Sites
The presence of ARNT with AhR at transcription sites prompted us
to further analyze the in vivo role of ARNT in recruiting AhR to
transcription sites. To this end, we used a mutant cell line that lacks
ARNT/HIF-1
protein (Legraverend et al., 1982
). These
cells do not support transcription of AhR target genes (Ko et
al., 1996
). A P450 1A1-luciferase reporter was cotransfected with
either an empty or an ARNT expression vector into the ARNT mutant
cells. The cells were treated with either DMSO as a control or TCDD,
and the reporter gene activity was assayed. Exogenous ARNT expression
resulted in sevenfold transactivation from the reporter gene consistent
with the idea that AhR-dependent transcription of a target gene can be
rescued by the overexpression of ARNT in these cells (Figure
7, ARNT; Li et al., 1994
). In
contrast, the empty expression vector had no effect (Figure 7,
control).
|
In cells lacking ARNT, dual-immunolabeling revealed that endogenous AhR
was absent from transcription sites (Figure
8C). The fluorescence intensity peaks
from both signals were clearly separated in a representative linescan,
suggesting that AhR is not recruited to the active transcription sites
(Figure 8G). Furthermore, the CCF analysis showed a strong decrease
around
X = 0, indicating that the majority of endogenous AhR
and nascent RNA distributions are mutually exclusive (Figure 8I). These
results demonstrate that ARNT is necessary for the recruitment of AhR
to transcription sites.
|
In cells with transiently expressed ARNT (determined by the
visualization of ARNT by using anti-ARNT antibody; our unpublished data), triple immunolabeling revealed a significant overlap
between endogenous AhR and active transcription sites (Figure 8F). This conclusion was verified by linescans, demonstrating that some, but not
all fluorescence intensity peaks from both signals frequently coincided, and by CCF analyses showing a positive correlation peak
around
X = 0 resulting from a nonrandom colocalization between two distributions (Figure 8, H and J). These results show that reintroduction of ARNT into ARNT mutant cells restores the recruitment of endogenous AhR to transcription sites. Quantitation of the colocalization percentages as described in MATERIALS AND METHODS showed
that in ARNT expressing cells, 36% of endogenous AhR distribution colocalized with active transcription sites (Table 1). This is similar
to the percentage of GFP-AhR colocalization with active transcription
sites in AhR-deficient, ARNT positive cells (Figure 4 and Table 1). In
cells lacking ARNT, the percentage of colocalization between endogenous
AhR and transcription sites was 10%, which is similar to the random
colocalization of GFP-AhR with NuMa (online supplemental material and
Table 1). From these results we conclude that ARNT/HIF-1
is
necessary and sufficient for the recruitment of endogenous AhR to the
sites of active transcription.
| |
DISCUSSION |
|---|
|
|
|---|
Using quantitative imaging methodology, we have found a strong spatial and functional relationship between the distribution of AhR/ARNT transcription factor complexes and active transcription sites. After ligand treatment, both the GFP-AhR and the endogenous AhR rapidly translocate to the nucleus and distribute in multiple bright foci (Figures 1 and 2). Furthermore, endogenous ARNT localizes to the nucleus in numerous small foci both in the absence and presence of a ligand (Figure 1).
Several lines of evidence suggest that the GFP-AhR fusion protein
behaves identically to endogenous AhR. The level of GFP-AhR expression
was very similar to the level of endogenous AhR expression (Figure 2B).
Ligand- and GFP-AhR-dependent transactivation from the reporter gene
in AhR-deficient cells (Figure 2C) was comparable with the ligand- and
endogenous AhR-dependent transactivation in wild-type Hepa-1 cells (Li
et al., 1994
). Intracellular distribution characteristics of
GFP-AhR followed the temporal and spatial distribution characteristics
of endogenous AhR (Figures 1 and 2). Subpopulations of both GFP-AhR and
endogenous AhR were recruited to the active transcription sites
(Figures 4 and 8 and Table 1). Finally, in wild-type Hepa-1 cells
transiently expressing GFP-AhR, GFP-AhR, and endogenous AhR
distributions were colocalized (our unpublished observations),
indicating that the localization of the GFP-labeled receptor correctly
reflects the distribution of the endogenous protein.
The formation of intranuclear foci after ligand treatment is not unique
to AhR. In the presence of a ligand, steroid hormone receptors such as
estrogen, progesterone, and mineralocorticoid and
glucocorticoid hormone receptors form nuclear foci (van Steensel et al., 1995
; Fejes-Toth et al., 1998
; Lim
et al., 1999
; Hager et al., 2000
). Furthermore,
BRG1, TFIIH, and p53 transcription factors and CBP/p300 coactivator
have been shown to distribute in multiple foci throughout the
nucleoplasm (Grande et al., 1997
; Rubbi and Milner, 2000
;
von Mikecz et al., 2000
). However, the relationship of these
intranuclear foci to nuclear function, particularly transcription, has
been elusive.
By immunofluorescence labeling and confocal microscopy, van Steensel
et al. (1995)
reported that hormone-activated glucocorticoid receptor is concentrated in a large number of clusters in the nucleoplasm, but found that these clusters did not significantly colocalize with RNA polymerase II clusters, or with domains containing the splicing factor SC-35. They concluded that most of the
glucocorticoid receptor clusters are not directly involved in
activation of transcription. In a more recent study (Grande et
al., 1997
) the spatial relationship between newly synthesized RNA
and domains containing several proteins involved in transcription was
examined. A high degree of colocalization between the RNA polymerase II
and active transcription sites was observed, but no relationship was
found between the distribution of the glucocorticoid receptor, Oct1 or
E2F-1 and transcription sites.
In contrast to these reports, we find a strong correlation between the
intranuclear AhR distribution and sites of active transcription, indicating that a significant fraction of AhR is involved in activation of transcription. The disparity between our findings with AhR and the
previous glucocorticoid receptor results (van Steensel et
al., 1995
) could have several explanations. These are distinct transcription factors, and they may actually be organized in a different way in the nucleus. Alternatively, active glucocorticoid receptor sites of transcription may be too small to visualize by
fluorescent microscopy, or the percentage of GR sites associated with
active centers of transcription may be small.
Intranuclear GFP-AhR foci were sensitive to inhibition of transcription
by
-amanitin (Figure 3) and actinomycin D (our unpublished observations). Based upon the nuclear distribution characteristics of
AhR after ligand treatment (Figures 1 and 2) and during inhibition of
transcription (Figure 3), we concluded that there are at least two
populations of AhR proteins in the nucleus. One population is diffusely
distributed throughout the nucleoplasm and the second population is
distributed in multiple foci.
We also demonstrate that AhR is recruited to the sites of active
transcription by using a transcription assay that labels the nascent
RNA in situ with BrUTP incorporation (Jackson et al., 1993
;
Wansink et al., 1993
). This assay has been used in many studies to visualize the transcription pattern in the nucleus (Hozak
et al., 1994
; Aoki et al., 1997
; Fay et
al., 1997
; Huang et al., 1998
). Short BrUTP
incorporation periods, such as the 5-min incorporation period used in
our study, permit the detection of transcription initiation sites.
During a short incorporation period, the labeled nascent RNAs are not
transported and not subject to RNA processing (Jackson et
al., 1993
; Wansink et al., 1993
). In our labeling
conditions, ~1900 transcription sites per Hepa-1 cell nucleus were
detected. This is in close agreement with previous reports (Iborra
et al., 1996
; Pombo and Cook, 1996
). Labeling of
transcription sites was sensitive to
-amanitin, suggesting that AhR
is recruited most likely to the sites of transcription by RNA
polymerase II.
To analyze quantitatively the intranuclear distributions of AhR, ARNT
proteins, and transcription sites, we used linescans and CCF analyses
(van Steensel et al., 1996
; Grande et al., 1997
). We find that subpopulations of AhR (35%) and ARNT (33%) are both targeted to the sites of active transcription (Figure 4 and Table 1). A
fraction of AhR population (38%) also associates with ARNT (Figure 5
and Table 1), consistent with reports that AhR coimmunoprecipitates with ARNT (Probst et al., 1993
). The in vivo association of
AhR with ARNT at transcription sites (Figure 6) is consistent with the
biochemical data suggesting that AhR heterodimerizes with ARNT, and
AhR/ARNT heterodimeric complex binds to the regulatory regions of
target genes and activates the transcription (Hankinson, 1995
;
Whitlock, 1999
). Presently, we cannot assign a functional role to those
AhR and ARNT sites that are not associated with active transcription
sites in the nucleus. These sites may represent supply or storage sites
from which AhR and ARNT can be recruited when necessary, or
alternatively, may be involved in other transcription-related cellular processes.
In cells lacking ARNT expression, ligand- and AhR-dependent transcriptional activation from the P450 1A1 reporter gene required exogenous expression of ARNT protein (Figure 7). In the same cells, endogenous AhR was absent from active transcription sites (Figure 8). However, exogenous ARNT expression restored the recruitment of endogenous AhR to the active transcription sites (Figure 8). These results imply that ARNT is both necessary and sufficient for the recruitment of AhR to the active transcription sites. Taken together, our data support a model that after the addition of a ligand, AhR rapidly translocates to the nucleus and localizes in multiple foci with diffuse distribution. In the nucleoplasm, a subpopulation of AhR proteins is dynamically recruited by ARNT, possibly from a diffuse nuclear pool of AhR to specific nuclear domains with transcriptional activity.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dr. O. Hankinson for providing pcDNAI/Neo/mARNT; Dr. D. Pasco for providing P1A1-4X1-LUC and P1A1-LUC; and Dr. F.J. Gonzalez for providing pCI/AhR expression vectors. We thank Dr. T. Karpova for suggestions on imaging. Imaging was carried out in the Fluorescence Imaging Facility, Laboratory of Receptor Biology and Gene Expression, National Cancer Institute.
| |
FOOTNOTES |
|---|
* Corresponding author. E-mail address: hagerg{at}exchange.nih.gov.
DOI: 10.1091/mbc.02-01-0009.
| |
ABBREVIATIONS |
|---|
Abbreviations used:
AhR, aryl hydrocarbon (dioxin) receptor;
ARNT/HIF-1
, aryl hydrocarbon receptor nuclear
translocator/hypoxia-inducible factor 1
;
bHLH/PAS, basic
helix-loop-helix/Period-ARNT-Sim;
BrUTP, 5-bromouridine
5'-triphosphate;
CCF, cross-correlation function;
DAPI, diamidino-phenylindole, dihydrochloride;
GFP, green fluorescence
protein;
Rp, Pearson's correlation coefficient;
TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin;
XREs, xenobiotic
response elements.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
I. S. Fenne, T. Hoang, M. Hauglid, J. V. Sagen, E. A. Lien, and G. Mellgren Recruitment of Coactivator Glucocorticoid Receptor Interacting Protein 1 to an Estrogen Receptor Transcription Complex Is Regulated by the 3',5'-Cyclic Adenosine 5'-Monophosphate-Dependent Protein Kinase Endocrinology, September 1, 2008; 149(9): 4336 - 4345. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Johnson, C. Elbi, B. S. Parekh, G. L. Hager, and S. John Chromatin Remodeling Complexes Interact Dynamically with a Glucocorticoid Receptor-regulated Promoter Mol. Biol. Cell, August 1, 2008; 19(8): 3308 - 3322. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zappala, C. Elbi, J. Edwards, J. Gorenstein, M. M. Rechler, and N. Bhattacharyya Induction of Apoptosis in Human Prostate Cancer Cells by Insulin-Like Growth Factor Binding Protein-3 Does Not Require Binding to Retinoid X Receptor-{alpha} Endocrinology, April 1, 2008; 149(4): 1802 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Muller, D. Rieder, T. S. Karpova, S. John, Z. Trajanoski, and J. G. McNally Organization of chromatin and histone modifications at a transcription site J. Cell Biol., July 30, 2007; 177(6): 957 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Carnevale, C. J. Proietti, M. Salatino, A. Urtreger, G. Peluffo, D. P. Edwards, V. Boonyaratanakornkit, E. H. Charreau, E. B. de Kier Joffe, R. Schillaci, et al. Progestin Effects on Breast Cancer Cell Proliferation, Proteases Activation, and in Vivo Development of Metastatic Phenotype All Depend on Progesterone Receptor Capacity to Activate Cytoplasmic Signaling Pathways Mol. Endocrinol., June 1, 2007; 21(6): 1335 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Pollenz, S. E. Wilson, and E. J. Dougherty Role of Endogenous XAP2 Protein on the Localization and Nucleocytoplasmic Shuttling of the Endogenous Mouse Ahb-1 Receptor in the Presence and Absence of Ligand Mol. Pharmacol., October 1, 2006; 70(4): 1369 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bhattacharyya, K. Pechhold, H. Shahjee, G. Zappala, C. Elbi, B. Raaka, M. Wiench, J. Hong, and M. M. Rechler Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus J. Biol. Chem., August 25, 2006; 281(34): 24588 - 24601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. M. Schaaf, L. Willetts, B. P. Hayes, B. Maschera, E. Stylianou, and S. N. Farrow The Relationship between Intranuclear Mobility of the NF-{kappa}B Subunit p65 and Its DNA Binding Affinity J. Biol. Chem., August 4, 2006; 281(31): 22409 - 22420. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Stavreva, M. Kawasaki, M. Dundr, K. Koberna, W. G. Muller, T. Tsujimura-Takahashi, W. Komatsu, T. Hayano, T. Isobe, I. Raska, et al. Potential Roles for Ubiquitin and the Proteasome during Ribosome Biogenesis Mol. Cell. Biol., July 1, 2006; 26(13): 5131 - 5145. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Farla, R. Hersmus, J. Trapman, and A. B. Houtsmuller Antiandrogens prevent stable DNA-binding of the androgen receptor J. Cell Sci., September 15, 2005; 118(18): 4187 - 4198. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. He, J.-M. Sun, L. Li, and J. R. Davie Differential Intranuclear Organization of Transcription Factors Sp1 and Sp3 Mol. Biol. Cell, September 1, 2005; 16(9): 4073 - 4083. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. M. Schaaf, L. J. Lewis-Tuffin, and J. A. Cidlowski Ligand-Selective Targeting of the Glucocorticoid Receptor to Nuclear Subdomains Is Associated with Decreased Receptor Mobility Mol. Endocrinol., June 1, 2005; 19(6): 1501 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Jacobsen, S. A. Schittone, J. K. Richer, and K. B. Horwitz Progesterone-Independent Effects of Human Progesterone Receptors (PRs) in Estrogen Receptor-Positive Breast Cancer: PR Isoform-Specific Gene Regulation and Tumor Biology Mol. Endocrinol., March 1, 2005; 19(3): 574 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Intine, M. Dundr, A. Vassilev, E. Schwartz, Y. Zhao, Y. Zhao, M. L. DePamphilis, and R. J. Maraia Nonphosphorylated Human La Antigen Interacts with Nucleolin at Nucleolar Sites Involved in rRNA Biogenesis Mol. Cell. Biol., December 15, 2004; 24(24): 10894 - 10904. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Phair, P. Scaffidi, C. Elbi, J. Vecerova, A. Dey, K. Ozato, D. T. Brown, G. Hager, M. Bustin, and T. Misteli Global Nature of Dynamic Protein-Chromatin Interactions In Vivo: Three-Dimensional Genome Scanning and Dynamic Interaction Networks of Chromatin Proteins Mol. Cell. Biol., July 15, 2004; 24(14): 6393 - 6402. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, B. L. Dancheck, L. C. Trifiletti, R. E. Birnkrant, B. J. Taylor, S. H. Garfield, U. Thorgeirsson, and L. M. De Luca Altered Localization of Retinoid X Receptor {alpha} Coincides with Loss of Retinoid Responsiveness in Human Breast Cancer MDA-MB-231 Cells Mol. Cell. Biol., May 1, 2004; 24(9): 3972 - 3982. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fan, T. Yanase, Y. Wu, H. Kawate, M. Saitoh, K. Oba, M. Nomura, T. Okabe, K. Goto, J. Yanagisawa, et al. Protein Kinase A Potentiates Adrenal 4 Binding Protein/Steroidogenic Factor 1 Transactivation by Reintegrating the Subcellular Dynamic Interactions of the Nuclear Receptor with Its Cofactors, General Control Nonderepressed-5/Transformation/ Transcription Domain-Associated Protein, and Suppressor, Dosage-Sensitive Sex Reversal-1: a Laser Confocal Imaging Study in Living KGN Cells Mol. Endocrinol., January 1, 2004; 18(1): 127 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Spink, B. H. Katz, M. M. Hussain, B. T. Pentecost, Z. Cao, and B. C. Spink Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells Carcinogenesis, December 1, 2003; 24(12): 1941 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. O'Toole, T. Inoue, L. Emerson, I. E. G. Morrison, A. R. Mackie, R. J. Cherry, and J. D. Norton Id Proteins Negatively Regulate Basic Helix-Loop-Helix Transcription Factor Function by Disrupting Subnuclear Compartmentalization J. Biol. Chem., November 14, 2003; 278(46): 45770 - 45776. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Hestermann and M. Brown Agonist and Chemopreventative Ligands Induce Differential Transcriptional Cofactor Recruitment by Aryl Hydrocarbon Receptor Mol. Cell. Biol., November 1, 2003; 23(21): 7920 - 7925. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||